Gene · 4616
Papers2,130
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,130
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer. | Cancer Res | 2023 | 37350664 | PubTator, text mining | PubMed |
| Modelling viral encephalitis caused by herpes simplex virus 1 infection in cerebral organoids. | Nat Microbiol | 2023 | 37349587 | PubTator, text mining | PubMed |
| Characterization of a rhabdomyosarcoma reveals a critical role for SMG7 in cancer cell viability and tumor growth. | Sci Rep | 2023 | 37349371 | PubTator, text mining | PubMed |
| Regulation of T cell differentiation and function by long noncoding RNAs in homeostasis and cancer. | Front Immunol | 2023 | 37346034 | PubTator, text mining | PubMed |
| Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management. | Cancers (Basel) | 2023 | 37345083 | PubTator, text mining | PubMed |
| Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients. | Front Oncol | 2023 | 37342196 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views. | J Transl Med | 2023 | 37291585 | PubTator, text mining | PubMed |
| Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. | Pharmaceuticals (Basel) | 2023 | 37259344 | PubTator, text mining | PubMed |
| Tight basis cycle representatives for persistent homology of large biological data sets. | PLoS Comput Biol | 2023 | 37253074 | PubTator, text mining | PubMed |
| Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B. | MedComm (2020) | 2023 | 37250145 | PubTator, text mining | PubMed |
| A Novel Synthetic Oleanolic Acid Derivative Inhibits Glioma Cell Proliferation by Regulating Cell Cycle G2/M Arrest. | Pharmaceuticals (Basel) | 2023 | 37242425 | PubTator, text mining | PubMed |
| Discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-seq differential expression analysis with machine learning. | Front Microbiol | 2023 | 37234545 | PubTator, text mining | PubMed |
| Role of epithelial cell-mesenchymal transition regulators in molecular typing and prognosis of colon cancer. | J Gastrointest Oncol | 2023 | 37201067 | PubTator, text mining | PubMed |
| Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy. | Mol Ther Nucleic Acids | 2023 | 37200859 | PubTator, text mining | PubMed |
| Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers. | Cancers (Basel) | 2023 | 37190316 | PubTator, text mining | PubMed |
| Patient-Specific iPSC-Derived Models Link Aberrant Endoplasmic Reticulum Stress Sensing and Response to Juvenile Osteochondritis Dissecans Etiology. | Stem Cells Transl Med | 2023 | 37184892 | PubTator, text mining | PubMed |
| Changes in the mammary gland during aging and its links with breast diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37184281 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential. | Cells | 2023 | 37174714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4616/papers?page=11